Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer

Costa, Ana, Kieffer, Yann, Scholer-Dahirel, Alix, Pelon, Floriane, Bourachot, Brigitte, Cardon, Melissa, Sirven, Philemon, Magagna, Ilaria, Fuhrmann, Laetitia, Bernard, Charles, Bonneau, Claire, Kondratova, Maria, Kuperstein, Inna, Zinovyev, Andrei, Givel, Anne-Marie, Parrini, Maria-Carla, Soumelis, Vassili, Vincent-Salomon, Anne, Mechta-Grigoriou, Fatima·2018·Cancer Cell

Cited by (1,002)

Items 601–700 of 1,002

  1. Expression of long noncoding RNAs in cancer‐associated fibroblasts linked to patient survival in ovarian cancer
    Emily K. Colvin, Viive Maarika Howell, Samuel C. Mok, Goli Samimi, Fatemeh Vafaee · 2020 · Cancer Science
  2. Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components
    Parisa Amini, Sina Nassiri, Alexandra J. Malbon, Enni Markkanen · 2020 · Scientific Reports
  3. ACKR4 restrains antitumor immunity by regulating CCL21
    Carly E. Whyte, Maleika Osman, Ervin E. Kara, Caitlin A. Abbott, Jade Foeng, Duncan R. McKenzie, Kevin Aaron Fenix, Yuka Harata‐Lee, Kerrie L. Foyle, Sarah Theresa Boyle et al. · 2020 · The Journal of Experimental Medicine
  4. Immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma: Relationship with histopathological and molecular classifications
    Yutaka Kurebayashi, Naoto Kubota, Michiie Sakamoto · 2020 · Hepatology Research
  5. Mitochondria at Center of Exchanges between Cancer Cells and Cancer-Associated Fibroblasts during Tumor Progression
    Lisa Nocquet, Philippe Paul Juin, Frédérique Souazé · 2020 · Cancers
  6. Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
    Priyanka Hirani, Valentine Gauthier, Carys E. Allen, Thomas N. Wight, Oliver M.T. Pearce · 2021 · Frontiers in Oncology
  7. The Advancing Roles of Exosomes in Breast Cancer
    Xi Wang, Chunxiao Sun, Xiang Huang, Jun Li, Ziyi Fu, Wei Li, Yongmei Yin · 2021 · Frontiers in Cell and Developmental Biology
  8. Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases
    Pellegata, Natalia S., Berriel Diaz, Mauricio, Rohm, Maria, Herzig, Stephan · 2022 · Cancer and Metastasis Reviews
  9. Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer
    Yan Zhao, Yueping Liu, Yunlong Jia, Xiaoxiao Wang, Jiankun He, Shuman Zhen, Jiali Wang, Lihua Liu · 2022 · Journal of Cancer Research and Clinical Oncology
  10. AI powered quantification of nuclear morphology in cancers enables prediction of genome instability and prognosis
    John Abel, Suyog Dutt Jain, Deepta Rajan, Harshith Padigela, Kenneth Leidal, Aaditya Prakash, Jake R. Conway, Michael Nercessian, Christian Kirkup, Syed Ashar Javed et al. · 2024 · npj Precision Oncology
  11. AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization
    Zhen-Kun Liu, Siyuan Hu, Xinlei Zhao, Wen-Xin Xu, Feng Ju, Meiying Gu, Jialei Weng, Yabing Du · 2024 · Journal for ImmunoTherapy of Cancer
  12. Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
    Keke Lv, Tianlin He · 2024 · Molecular Biomedicine
  13. Molecular Heterogeneity and Evolution in Breast Cancer
    Jennifer Lee Caswell-Jin, Carina Lorenz, Christina N. Curtis · 2020 · Annual Review of Cancer Biology
  14. Overcoming biological barriers to improve solid tumor immunotherapy
    Anvay Ukidve, Katharina Cu, Ninad Kumbhojkar, Joerg Lahann, Samir Mitragotri · 2021 · Drug Delivery and Translational Research
  15. Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor–Stroma Cross-talk
    Hui Wang, Haibo Xu, Wei Chen, Mei Cheng, Li Zou, Qin Yang, Chi Bun Chan, Hao Zhu, Ceshi Chen, Jianyun Nie et al. · 2022 · Cancer Research
  16. Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts
    Yao-Tsung Tsai, Chih-Yi Li, Yen‐Hua Huang, Te‐Sheng Chang, Chung‐Yen Lin, Chia-Hsien Chuang, Chih‐Yang Wang, Gangga Anuraga, Tzu-Hao Chang, Tsung‐Chieh Shih et al. · 2022 · Oncogene
  17. Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition
    Roger J. Daly, Andrew Mark Scott, Oliver Klein, Matthias Ernst · 2022 · Molecular Cancer
  18. Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives
    Christopher Jon Hanley, Gareth J. Thomas · 2021 · Oncotarget
  19. Cancer‐associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
    Durre Aden, Sufian Zaheer, Himani Ahluwalia, Sunil Ranga · 2023 · Cell Biology International
  20. Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment
    Satoru Furuhashi, Matias Alberto Bustos, Shodai Mizuno, Suyeon Ryu, Yalda B. Naeini, Anton J. Bilchik, Dave S.�B. Hoon · 2023 · npj Precision Oncology
  21. Identification of Periostin as a critical niche for myofibroblast dynamics and fibrosis during tendon healing
    Jessica E. Ackerman, Samantha N. Muscat, Emmanuela Adjei‐Sowah, Antonion Korcari, Anne E. C. Nichols, Mark R. Buckley, Alayna E. Loiselle · 2023 · Matrix Biology
  22. CD63+ cancer-associated fibroblasts confer CDK4/6 inhibitor resistance to breast cancer cells by exosomal miR-20
    Jiahui Sun, Ruoxin Du, Xiaoju Li, Chenlin Liu, Donghui Wang, Xiangmei He, Guodong Li, Kuo Zhang, Shuning Wang, Qiang Hao et al. · 2024 · Cancer Letters
  23. Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance
    Yumin Fu, Xinyu Guo, Linmao Sun, Tianming Cui, Chenghui Wu, Jiabei Wang, Yao Liu, Lianxin Liu · 2024 · eLife
  24. Stress responses in stromal cells and tumor homeostasis
    Ilio Vitale, Gwenola Manic, Claudia Galassi, Lorenzo Galluzzi · 2019 · Pharmacology & Therapeutics
  25. CD49b, CD87, and CD95 Are Markers for Activated Cancer-Associated Fibroblasts Whereas CD39 Marks Quiescent Normal Fibroblasts in Murine Tumor Models
    David Agorku, Anne Langhammer, Ute Heider, Stefan Wild, Andreas Bosio, Olaf Hardt · 2019 · Frontiers in Oncology
  26. Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response
    Vasudeva Bhat, Alison L. Allan, Afshin Raouf · 2019 · Cancers
  27. CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
    Cristiana Tănase, Ancuța-Augustina Gheorghișan-Gălățeanu, Ionela Daniela Popescu, Simona Mihai, Elena Codrici, Radu Albulescu, Mihail Eugen Hinescu · 2020 · International Journal of Molecular Sciences
  28. Overcoming Stromal Barriers to Immuno-Oncological Responses via Fibroblast Activation Protein-Targeted Therapy
    William Nathaniel Brennen, Daniel L.J. Thorek, Wen Jiang, Timothy E. G. Krueger, Lizamma Antony, Samuel Ray Denmeade, John T. Isaacs · 2020 · Immunotherapy
  29. A CD10‐OGP Membrane Peptolytic Signaling Axis in Fibroblasts Regulates Lipid Metabolism of Cancer Stem Cells via SCD1
    Shubin Yu, Yiwen Lu, An Su, Jianing Chen, Jiang Li, Boxuan Zhou, Xinwei Liu, Qi‐Dong Xia, Yihong Li, Jiaqian Li et al. · 2021 · Advanced Science
  30. The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma Determines Cancer Associated Fibroblast Growth
    Kyle Bond, Takuto Chiba, Kieran J. Wynne, Calvin Vary, Sunder Sims‐Lucas, Jeannine M. Coburn, Leif H. Oxburgh · 2021 · Cancers
  31. Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer
    Tomohiko Shinkawa, Kenoki Ohuchida, Masafumi Nakamura · 2022 · Cancers
  32. A Cdh3-β-catenin-laminin signaling axis in a subset of breast tumor leader cells control leader cell polarization and directional collective migration
    Priscilla Y. Hwang, Jairaj Mathur, Yanyang Cao, J. A. Afonso de Almeida, Jiayu Ye, Vasilios Aris Morikis, Daphne Cornish, Maria Clarke, Sheila A. Stewart, Amit Pathak et al. · 2023 · Developmental Cell
  33. Mesenchymal Stem/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization
    Víctor Adrián Cortés-Morales, Luis Chávez-Sanchéz, Leticia Rocha‐Zavaleta, Sandra Espíndola-Garibay, Alberto Monroy-García, Marta Elena Castro-Manrreza, Guadalupe Rosario Fajardo-Orduña, Teresa Apresa-García, Marcos Gutiérrez de la Barrera, Héctor Mayani et al. · 2023 · Cells
  34. The plasticity of fibroblasts: A forgotten player in the aging process
    Antero Salminen · 2023 · Ageing Research Reviews
  35. Sctensor detects many-to-many cell–cell interactions from single cell RNA-sequencing data
    Koki Tsuyuzaki, Manabu Ishii, Itoshi Nikaido · 2023 · BMC Bioinformatics
  36. Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution
    Evangelos Tzoras, Ioannis Zerdes, Nikos Tsiknakis, Georgios C. Manikis, Artur Mezheyeuski, Jonas C. S. Bergh, Alexios Matikas, Theodoros Foukakis · 2022 · Cancers
  37. The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting
    Natsuki Furukawa, Vered Stearns, Cesar Augusto Santa-Maria, Aleksander S. Popel · 2022 · Expert Opinion on Therapeutic Targets
  38. Everybody needs good neighbours: the progressive DCIS microenvironment
    Shayin V. Gibson, Reza Roozitalab, Michael D. Allen, J. Louise Jones, Edward P. Carter, Richard Philip Grose · 2023 · Trends in cancer
  39. Lobular Carcinoma of the Breast: A Comprehensive Review with Translational Insights
    Harsh Vardhan Batra, Jason Aboudi Mouabbi, Qingqing Ding, Ayşegül A. Şahin, Maria Gabriela Raso · 2023 · Cancers
  40. Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
    Steven E. Reid, Jessica Pantaleo, Paulina Bolívar, Matteo Bocci, Jonas Sjölund, Mikkel Morsing, Eugenia Cordero, Sara Larsson, Maria Malmberg, Brinton A. Seashore-Ludlow et al. · 2024 · Oncogene
  41. Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy
    Zaigang Zhou, Wenjuan Luo, Chunjuan Zheng, Haoxiang Wang, Rui Hu, Hui Deng, Jianliang Shen · 2024 · Acta Pharmaceutica Sinica B
  42. Breaking Apoptosis‐Induced Immune Silence: Ultrasound‐Activated Nano‐Oncolytic Therapy Reinvigorates Antitumor Immunity
    Mingxiao Fang, Jun Zheng, Qiuya Song, Ju Huang, Ran Cao, Pan Li, Yu Chen, Liang Zhang · 2025 · Advanced Materials
  43. SAA1 is upregulated in gastric cancer-associated fibroblasts possibly by its enhancer activation
    Yoshimi Yasukawa, Naoko Hattori, Naoko Iida, Hideyuki Takeshima, Masahiro Maeda, Tohru Kiyono, Shigeki Sekine, Yasuyuki Seto, Toshikazu Ushijima · 2020 · Carcinogenesis
  44. Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT
    Katharina Dendl, Stefan Alexander Koerber, Sebastian Adeberg, Manuel Röhrich, Clemens Kratochwil, Uwe Haberkorn, Frederik Lars Giesel · 2021 · European Journal of Nuclear Medicine and Molecular Imaging
  45. Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
    Gina Bouchard, Fernando Jose Garcia-Marques, Loukia Georgiou Karacosta, Weiruo Zhang, Abel Bermudez, Nicholas McIlvain Riley, Sushama Varma, Lindsey Catherine Mehl, Jalen Anthony Benson, Joseph B. Shrager et al. · 2021 · Cancer Research
  46. SPARC in cancer‐associated fibroblasts is an independent poor prognostic factor in non‐metastatic triple‐negative breast cancer and exhibits pro‐tumor activity
    Lindsay B. Alcaraz, Aude Mallavialle, Caroline Mollévi, Florence Boissière‐Michot, Hanane Mansouri, Joëlle Simony-Lafontaine, Valérie Laurent‐Matha, Thierry Chardès, William Jacot, Andrei Turtoï et al. · 2022 · International Journal of Cancer
  47. The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation?
    Asia Marangio, Andrea Biccari, Edoardo D’Angelo, Francesca Sensi, Gaya Spolverato, Salvatore Pucciarelli, Marco Agostini · 2022 · Cancers
  48. A tale of exosomes and their implication in cancer
    Abhay Mishra, Prahalad Singh Bharti, Neerja Rani, Fredrik K. Nikolajeff, Saroj Kumar · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  49. Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors
    Luana Guimarães de Sousa, Daniel James McGrail, Felippe Lazar Neto, Kaiyi Li, Mario Luiz Marques-Piubelli, Sammy Ferri Borgogno, Hui Dai, Yoshitsugu Mitani, Nicole Spardy Burr, Zachary Aaron Cooper et al. · 2023 · Clinical Cancer Research
  50. Enhancer reprogramming promotes the activation of cancer-associated fibroblasts and breast cancer metastasis
    Qian Li, Xuejiao Lv, Chunyong Han, Yu Kong, Zhongye Dai, Dawei Huo, Ting Li, Dapeng Li, Wei Li, Xing Wang et al. · 2022 · Theranostics
  51. Key aspects for conception and construction of co-culture models of tumor-stroma interactions
    James E. Mason, Daniel Öhlund · 2023 · Frontiers in Bioengineering and Biotechnology
  52. Simultaneous isolation of hormone receptor–positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms
    Jenny Högström, Kayla A. Cruz, Laura M. Selfors, Madelyn N. Ward, Tejas S. Mehta, Naama Kanarek, J. Philips, Vandana M. Dialani, Gerburg M. Wulf, Laura C. Collins et al. · 2023 · Journal of Biological Chemistry
  53. Nanomedicine Strategies for Targeting Tumor Stroma
    Mei‐Chi Su, Susheel Kumar Nethi, Pavan Kumar Dhanyamraju, Swayam Prabha · 2023 · Cancers
  54. Extracellular vesicles promote activation of pro-inflammatory cancer-associated fibroblasts in oral cancer
    Julia Arebro, Rebecca M. Towle, Che-Min Lee, Kevin L. Bennewith, Cathie Garnis · 2023 · Frontiers in Cell and Developmental Biology
  55. Rebuilding the microenvironment of primary tumors in humans: a focus on stroma
    Siwon Mun, Hyun Jin Lee, Pilnam Kim · 2024 · Experimental & Molecular Medicine
  56. Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer
    Guangfa Bao, Ziqiang Wang, Luoxia Liu, Buchuan Zhang, Shuang Song, Dongdong Wang, Siyuan Cheng, E S Moon, Frank Roesch, Jun Zhao et al. · 2024 · European Journal of Nuclear Medicine and Molecular Imaging
  57. The role of host environment in cancer evolution
    Éric Solary, Lucie Laplane · 2020 · Evolutionary Applications
  58. A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer
    Iris Nederlof, Hugo M. Horlings, Christina N. Curtis, Marleen Kok · 2021 · Cancers
  59. Tumor Microenvironment in Metastatic Colorectal Cancer: The Arbitrator in Patients’ Outcome
    Cristina Galindo-Pumariño, Manuel Collado, Mercedes Herrera, Cristina Peña · 2021 · Cancers
  60. CD34+ Stromal Cells/Telocytes as a Source of Cancer-Associated Fibroblasts (CAFs) in Invasive Lobular Carcinoma of the Breast
    Lucio Díaz‐Flores, Ricardo Gutiérrez, Miriam González‐Gómez, Maria Pino García, Lucio Díaz-Flores, José Luís Carrasco, Pablo Martı́n-Vasallo · 2021 · International Journal of Molecular Sciences
  61. Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship
    Madhura R. Pandkar, Shruti Ganesh Dhamdhere, Sanjeev Shukla · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  62. Immunobiology of cancer-associated fibroblasts in the context of radiotherapy
    Turid Hellevik, Rodrigo Berzaghi, Kristin Lode, Ashraful Islam, Iñigo Martínez-Zubiaurre · 2021 · Journal of Translational Medicine
  63. Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance
    Hyungjoo Kim, Je‐Min Choi, Kyung‐min Lee · 2022 · Biomedicines
  64. Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies
    Carmen Belli, Gabriele Antonarelli, Matteo Repetto, Luca Boscolo Bielo, Edoardo Crimini, Giuseppe Curigliano · 2022 · Cancers
  65. Deciphering cancer fibroblasts
    Giulia Biffi, David A. Tuveson · 2018 · The Journal of Experimental Medicine
  66. Influence of Innate Immunity on Cancer Cell Stemness
    Anna Pastò, Francesca Maria Consonni, Antonio Sica · 2020 · International Journal of Molecular Sciences
  67. Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis
    Pengpeng Zhang, Shiyang Dong, Wei Sun, Wan Zhong, Jingwen Xiong, Xiangjin Gong, Jun Li, Haoran Lin, Zhuang Yu · 2023 · Frontiers in Molecular Biosciences
  68. Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas
    Răzvan Onciul, Felix-Mircea Brehar, Corneliu Toader, Răzvan-Adrian Covache-Busuioc, Luca-Andrei Glavan, Bogdan-Gabriel Bratu, Horia Petre Costin, David-Ioan Dumitrascu, Matei Șerban, Alexandru Vlad Ciurea · 2024 · Current Issues in Molecular Biology
  69. Targeting Treg–fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinoma
    Aldo Prawira, Hang Xu, Yu Mei, Wei Qiang Leow, N. Jannah M. Nasir, Marie J. Y. Reolo, Masayuki Otsuka, Mohammad Rahbari, Ziyao Chen, Madhushanee Weerasooriya et al. · 2025 · Gut
  70. “Prostate telocytes change their phenotype in response to castration or testosterone replacement”
    Sérgio Luís Felisbino, Bruno D. A. Sanches, Flávia Karina Delella, Wellerson Rodrigo Scarano, Fernanda Cristina Alcântara dos Santos, Patrícia Simone Leite Vilamaior, Sebastião Roberto Taboga, Luís Antônio Justulin · 2019 · Scientific Reports
  71. 68Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation
    Ida Sonni, Stephanie Lee‐Felker, Sanaz Memarzadeh, Molly M. Quinn, Christine E. Mona, Katharina Lückerath, Johannes G. Czernin, Jérémie Calais · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
  72. Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
    Raquel Muñoz, Alessandra Girotti, Denise Hileeto, Francisco Javier Arias · 2021 · Cancers
  73. Targeting Tumour-Associated Fibroblasts in Cancers
    Kairav Shah, Sanchari Basu Mallik, Praveer K. Gupta, Abishek Iyer · 2022 · Frontiers in Oncology
  74. Overcoming cancer treatment resistance: Unraveling the role of cancer-associated fibroblasts
    Xiaoyuan Wang, Yinuo Zhou, Yingzhuo Wang, Jiaxin Yang, Zhengqian Li, F L Liu, Anni Wang, Zhenhao Gao, Chen Hsuan Wu, Hang Yin · 2025 · Journal of the National Cancer Center
  75. Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity
    Fátima María Mentucci, María Gracia Ferrara, Agustina Ercole, Natalia Belén Rumie Vittar, María Julia Lamberti · 2025 · Frontiers in Immunology
  76. Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes
    Hilde Ytre‐Hauge Smeland, Cecilie Askeland, Elisabeth Wik, Gøril Knutsvik, Anders Molven, Reidunn Jetne Edelmann, Rolf Kåre Reed, David John Warren, Donald Gullberg, Linda E. B. Stuhr et al. · 2019 · The Journal of Pathology Clinical Research
  77. Intense Diffuse Uptake of 68Ga-FAPI-04 in the Breasts Found by PET/CT in a Patient With Advanced Nasopharyngeal Carcinoma
    Lijuan Wang, Yin Zhang, Hubing Wu · 2020 · Clinical Nuclear Medicine
  78. The role of the tumor matrix environment in progression of head and neck cancer
    Angélique Saint, Ellen Van Obberghen‐Schilling · 2021 · Current Opinion in Oncology
  79. Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors
    Yixin Shi, Ziren Kong, Penghao Liu, Guozhu Hou, Jiaming Wu, Wenbin Ma, Xin Cheng, Yu Wang · 2021 · Cells
  80. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime
    De Pradip, Jennifer Carlson Aske, Nandini Dey · 2021 · International Journal of Molecular Sciences
  81. Pirfenidone Reduces Epithelial–Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs)
    Hamidreza Aboulkheyr Es, Thomas R. Cox, Ehsan Sarafraz-Yazdi, Jean Paul Thiery, Majid Ebrahimi Warkiani · 2021 · Cancers
  82. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance
    Pradip K. De, Jennifer Carlson Aske, Raed A Sulaiman, Nandini Dey · 2022 · Cancers
  83. Modulation of the antitumor immune response by cancer-associated fibroblasts: mechanisms and targeting strategies to hamper their immunosuppressive functions
    Jérôme Thiery · 2022 · Exploration of Targeted Anti-tumor Therapy
  84. Reconstruction of the gastric cancer microenvironment after neoadjuvant chemotherapy by longitudinal single-cell sequencing
    Yingtai Chen, Jianhua Yin, Lulu Zhao, Guangyu Zhou, Shichen Dong, Yueming Zhang, Penghui Niu, Hu Ren, Tianjiao Zheng, Juan Yan et al. · 2022 · Journal of Translational Medicine
  85. Unique molecular signatures sustained in circulating monocytes and regulatory T cells in Convalescent COVID-19 patients
    Andrew Daniel Hoffmann, Samuel Edward Weinberg, Suchitra Swaminathan, Shuvam Mohan Chaudhuri, Hannah Faisal Almubarak, Matthew John Schipma, Chengsheng Mao, Xinkun Wang, Lamiaa El-Shennawy, Nurmaa Khund Dashzeveg et al. · 2022 · Clinical Immunology
  86. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments
    Xiaoxia Xue, Xiangpeng Wang, Mingshi Pang, Liuchunyang Yu, Jinxiu Qian, Xiaoyu Li, Meng Tian, Cheng Youn Lu, Cheng Xiao, Yuanyan Liu · 2024 · Journal of Nanobiotechnology
  87. Cancer‐Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets
    Yutao Li, Qingyun Liu, Xilin Jing, Yuqi Wang, Xiaohua Jia, Xing Yang, Kezhong Chen · 2025 · MedComm
  88. Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBC
    Qian Zhu, Akhila Balasubramanian, Jaya Ruth Asirvatham, Megha Chatterjee, Badrajee Piyarathna, Jaspreet Singh Kaur, Nada Mohamed, Ling Wu, Stacy Wang, Niloufar Pourfarrokh et al. · 2025 · Nature Communications
  89. B7-H3 in Cancer Immunotherapy—Prospects and Challenges: A Review of the Literature
    Sylwia Mielcarska, Anna Kot, Miriam Dawidowicz, Agnieszka Kula, Piotr Sobków, Daria Kłaczka, Dariusz Waniczek, Elżbieta Świętochowska · 2025 · Cells
  90. High-dimensional mass cytometry analysis revealed microenvironment complexity in chronic lymphocytic leukemia
    Marina Wierz, Bassam Janji, Guy Berchem, Etienne Moussay, Jérôme Paggetti · 2018 · OncoImmunology
  91. Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients
    Gaurav Chatterjee, Trupti Pai, Thomas Hardiman, Kelly A. Avery‐Kiejda, Rodney J. Scott, Jo Spencer, Sarah E. Pinder, Anita E. Grigoriadis · 2018 · Breast Cancer Research
  92. Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
    Lingli Yan, Bainan Liu · 2018 · OncoTargets and Therapy
  93. Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts
    Akiko Kogure, Yutaka Naito, Yusuke Yamamoto, Masakazu Yashiro, Tohru Kiyono, Kazuyoshi Yanagihara, Kosei Hirakawa, Takahiro Ochiya · 2020 · PLoS ONE
  94. The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns
    Gemma Garcia‐Vicién, Artur Mezheyeuski, María Bañuls, Núria Ruiz-Roig, David G. Mollevı́ · 2021 · International Journal of Molecular Sciences
  95. Discovery of β-carboline-(phenylsulfonyl)furoxan hybrids as potential anti-breast cancer agents
    Xu Hu, Xiang Gao, Gang Gao, Yanbing Wang, Hao Cao, Dahong Li, Huiming Hua · 2021 · Bioorganic & Medicinal Chemistry Letters
  96. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals distinct cancer-associated fibroblasts in head and neck squamous cell carcinoma
    Qian Zhang, Yuxin Wang, Chengwan Xia, Liang Ding, Yumei Pu, Xiaobei Hu, Huiming Cai, Qingang Hu · 2021 · Annals of Translational Medicine
  97. Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
    Brooke E. Wilson, Chiara Gorrini, David W. Cescon · 2021 · Breast Cancer Research and Treatment
  98. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer
    J. Suzuki, M. Tsuboi, G. Ishii · 2021 · Expert Review of Anticancer Therapy
  99. Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
    Maoli Wang, Ruifa Feng, Zihao Chen, Wenjie Shi, Cheng Li, Huiquan Liu, Kejin Wu, Dajin Li, Xiqing Li · 2022 · Journal of Oncology
  100. Interleukin-6 Signaling in Triple Negative Breast Cancer Cells Elicits the Annexin A1/Formyl Peptide Receptor 1 Axis and Affects the Tumor Microenvironment
    L. Vecchi, S. Mota, M. A. P. Zóia, I. C. Martins, Jessica Brito de Souza, T. Santos, Adriano de Oliveira Beserra, V. P. de Andrade, L. Goulart, T. Araújo · 2022 · Cells